Home950210 • KRX
add
Prestige Biopharma Ltd
Previous close
â‚©13,090.00
Day range
â‚©12,500.00 - â‚©13,220.00
Year range
â‚©11,000.00 - â‚©20,000.00
Market cap
754.21B KRW
Avg Volume
132.92K
P/E ratio
45.41
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 2.31B | 3.87% |
Operating expense | 24.39B | 94.85% |
Net income | -12.34B | -112.87% |
Net profit margin | -534.55 | -104.94% |
Earnings per share | — | — |
EBITDA | -18.82B | -64.52% |
Effective tax rate | 0.34% | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 134.81B | -40.29% |
Total assets | 714.76B | -0.26% |
Total liabilities | 215.44B | -5.55% |
Total equity | 499.31B | — |
Shares outstanding | 60.17M | — |
Price to book | 1.93 | — |
Return on assets | -8.31% | — |
Return on capital | -9.49% | — |
Cash Flow
Net change in cash
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -12.34B | -112.87% |
Cash from operations | -13.13B | 36.66% |
Cash from investing | 15.37B | 142.72% |
Cash from financing | -21.76B | -209.61% |
Net change in cash | -20.35B | 43.75% |
Free cash flow | -24.71B | -176.94% |
About
Founded
2015
Website
Employees
54